THERMOSTABLE LIPID NANOPARTICLE AND METHODS OF USE THEREOF

The present disclosure provides, among other things, a lipid nanoparticle adjuvant composition. The present disclosure provides pharmaceutical compositions that include a stable lipid nanoparticle adjuvant and human papillomavirus (HPV) virus-like particles (VLPs) of at least one type of human papil...

Full description

Saved in:
Bibliographic Details
Main Authors SKUDLAREK, JASON W, BETT, ANDREW, RAHEEM, IZZAT, STRABLE, ERICA L
Format Patent
LanguageEnglish
French
Published 23.02.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides, among other things, a lipid nanoparticle adjuvant composition. The present disclosure provides pharmaceutical compositions that include a stable lipid nanoparticle adjuvant and human papillomavirus (HPV) virus-like particles (VLPs) of at least one type of human papillomavirus (HPV) selected from the group consisting of HPV types: 6, 11, 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 55, 56, 58, 59, 66, 68, 73, and 82. La présente divulgation concerne, entre autres, une composition d'adjuvant de nanoparticules lipidiques. La présente divulgation concerne des compositions pharmaceutiques qui comprennent un adjuvant de nanoparticules lipidiques stables et des particules pseudo-virales (VLP) d'un papillomavirus humain (HPV) d'au moins un type de papillomavirus humain (HPV) choisi dans le groupe constitué par les types de HPV : 6, 11, 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 55, 56, 58, 59, 66, 68, 73 et 82.
Bibliography:Application Number: CA20223229064